PHARMA SOURCE - DME, INC.
NORTH MIAMI, FLORIDA

Pharma Source – DME, Inc. is a Florida-registered company committed to delivering high-quality services with competitive pricing. The firm prides itself on its qualified staff who ensure the best service for clients. Based in North Miami and operating under a Do-Not-Mail (DOMP) registration status, Pharma Source was incorporated on November 17, 1999. With its mailing address at 14025 West Dixie Hwy, North Miami, FL, 33161, the company can be reached at phone numbers (305) 899-0943 and (305) 899-0945. The organization's website is pharmasourcedme.com. A key aspect of their corporate governance includes a commitment to privacy for clients, subscribers, and contacts while maintaining transparency in operations. Recent business activities include an event on September 27, 2005, where there was a cancellation, administrative dissolution, or revival (CANCEL ADM DISS/REV), with the latest annual report filed on March 15, 2024. The company's identification within the state is noted by Fee Number: 650964827 and registered as P99000100599. At present, Estela Pinnavaria serves as a Principal Director Officer (PDO) of Pharma Source – DME, Inc., playing an integral role in steering the company's strategic direction.

KEY FACTS ABOUT PHARMA SOURCE - DME, INC.

Company name
PHARMA SOURCE - DME, INC.
Status
Active
Filed Number
P99000100599
FEI Number
650964827
Date of Incorporation
November 17, 1999
Age - 26 years
Home State
FL
Company Type
Domestic for Profit

CONTACTS

Website
http://pharmasourcedme.com
Phones
(305) 899-0943
(305) 899-0945

PHARMA SOURCE - DME, INC. NEAR ME

Principal Address
14025 WEST DIXIE HWY,
NORTH MIAMI,
FL,
33161

See Also

Officers and Directors

The PHARMA SOURCE - DME, INC. managed by the one person from NORTH MIAMI on following positions: PD

Estela Pinnavaria

Position
PD Active
From
NORTH MIAMI, FL





Registered Agent is Estela Pinnavaria

From
NORTH MIAMI, 33161

Events

September 27, 2005
CANCEL ADM DISS/REV
September 16, 2005
ADMIN DISSOLUTION FOR ANNUAL REPORT

Annual Reports

2025
March 19, 2025
2024
March 15, 2024